Related Experiment Video
Updated: Mar 12, 2026

Author Spotlight: Developing a Rat Model for Weight-Bearing Intervention to Investigate Osteonecrosis of the Femoral Head
Published on: September 27, 2024
Bone histomorphometric changes in children with rheumatic disorders on chronic glucocorticoids
Jennifer Harrington1,2, Douglas Holmyard3, Earl Silverman4,5
1Department of Pediatrics, Hospital for Sick Children, University of Toronto, Toronto, Canada. jennifer.harrington@sickkids.ca.
Children with rheumatic diseases on glucocorticoids show impaired bone micro-architecture and mineralization. These bone deficits correlate with glucocorticoid dose, impacting fracture risk in pediatric patients.
Area of Science:
- Pediatric Rheumatology
- Bone Biology
- Skeletal Health
Background:
- Rheumatic diseases increase fracture risk in children.
- Bone micro-architecture in pediatric rheumatic diseases is not well understood.
- Glucocorticoids used for rheumatic diseases can negatively impact bone health.
Purpose of the Study:
- To characterize bone micro-architecture in children with rheumatic diseases on chronic glucocorticoids.
- To investigate associations between bone micro-architecture and clinical/radiological factors.
- To assess bone mineralization in this pediatric cohort.
Main Methods:
- Trans-iliac bone biopsies were performed on children with rheumatic diseases and vertebral fractures.
- Histomorphometric analysis evaluated trabecular bone structure and osteoid parameters.
- Quantitative backscattered electron imaging (qBSE) assessed bone mineralization.
Main Results:
- Children showed decreased trabecular thickness, osteoid thickness, and osteoblast surface, with increased trabecular separation compared to norms.
- Trabecular deficits correlated with glucocorticoid dose, height, and BMI Z-scores.
- Bone mineralization was heterogeneous and hypermineralized, linked to cumulative glucocorticoid exposure.
Conclusions:
- Children with rheumatic diseases and vertebral fractures exhibit abnormal bone micro-architecture and mineralization.
- These bone abnormalities are associated with chronic glucocorticoid use.
- Findings highlight the detrimental effects of glucocorticoids on pediatric bone health in rheumatic diseases.
Related Concept Videos
Rheumatic Heart Disease I: Introduction
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Growth of Cartilage and Bone Tissue

